|
Post by digger on Mar 31, 2018 8:40:46 GMT -5
I think you misinterpreted what the "huge" problem was. He was not accusing spirometry of being a huge problem, but was pointing out the afrezza website for professionals was broken. The button that would take the doctor to the "learn more" page didn't work: "I can see a doctor attempting to learn, getting frustrated, and simply giving up." I can see what he means. When I attempt to click on "learn more," a "shade" -- I don't know the technical term -- saying "spirometry" falls and covers the button so I can't click on it. I don't know whether that's a "huge" problem but it is annoying. I just checked www.afrezza.com/hcp/ and had no problem, huge or otherwise, in "learning more" about Spirometry. I'm using Chrome as my Windows 10 browser. Maybe the problem has been fixed or it's only a problem for those using other browsers. I tried it using opera and it worked fine as well. Now, though, the doctors gets to see up front, "AFREZZA causes a decline in lung function over time as measured by FEV1," and probably doesn't read any further before going to check their email.
|
|
|
Post by porkini on Mar 31, 2018 10:16:28 GMT -5
I think you misinterpreted what the "huge" problem was. He was not accusing spirometry of being a huge problem, but was pointing out the afrezza website for professionals was broken. The button that would take the doctor to the "learn more" page didn't work: "I can see a doctor attempting to learn, getting frustrated, and simply giving up." I can see what he means. When I attempt to click on "learn more," a "shade" -- I don't know the technical term -- saying "spirometry" falls and covers the button so I can't click on it. I don't know whether that's a "huge" problem but it is annoying. I just checked www.afrezza.com/hcp/ and had no problem, huge or otherwise, in "learning more" about Spirometry. I'm using Chrome as my Windows 10 browser. Maybe the problem has been fixed or it's only a problem for those using other browsers. Yeah, I tested IE, Chrome, Firefox in Win 10, all worked, no problems. Problem exists between chair and keyboard? (PEBCAK)
|
|
|
Post by akemp3000 on Mar 31, 2018 10:23:12 GMT -5
The most convenient location for a meeting of Spencer, Adam and other like minds would be wherever Shkreli is confined
|
|
|
Post by boca1girl on Mar 31, 2018 10:34:09 GMT -5
It hurts to admit it, but he's right that there's a huge problem for physicians on one or more aspects of prescribing. If it's not spirometry, then what is it? Either that or we have a woefully underperforming sales team. Or perhaps both? For a variety of reasons I have had 5-6 Dr's (different) office visits in the last several months. In each case at least one, sometimes two different detail men/women=salespeople have come in, tried to see the Dr and was only allowed to fill out the sign in book and not see the Dr as too busy. I wonder how often even an excellent sales person can succeed if denied face to face time with the Dr's? I’ve seen the same thing happen. I’ve also noticed a “sales rep” sitting and waiting and then going in for only a few minutes and then leaving. I think this old sales approach of visiting doctor’s offices has limited effectiveness these days. If that rep was promoting Afrezza, would 3-5 minutes do any good in educating the doctor? I doubt it.
|
|
|
Post by goyocafe on Mar 31, 2018 10:55:27 GMT -5
For a variety of reasons I have had 5-6 Dr's (different) office visits in the last several months. In each case at least one, sometimes two different detail men/women=salespeople have come in, tried to see the Dr and was only allowed to fill out the sign in book and not see the Dr as too busy. I wonder how often even an excellent sales person can succeed if denied face to face time with the Dr's? I’ve seen the same thing happen. I’ve also noticed a “sales rep” sitting and waiting and then going in for only a few minutes and then leaving. I think this old sales approach of visiting doctor’s offices has limited effectiveness these days. If that rep was promoting Afrezza, would 3-5 minutes do any good in educating the doctor? I doubt it. If 1 in 10 take the time to visit with an Afrezza rep, and 1 in 10 of those were to buy into the reality of the story being told, that would amount to 1% of the market. Wouldn’t that amount to several hundred million dollars? Let’s get there one foot in front of the other. It is my expectation (not using “hope” any longer) that at some point the story will go viral and sales will go well beyond 1%.
|
|
|
Post by sportsrancho on Mar 31, 2018 11:17:15 GMT -5
I just checked www.afrezza.com/hcp/ and had no problem, huge or otherwise, in "learning more" about Spirometry. I'm using Chrome as my Windows 10 browser. Maybe the problem has been fixed or it's only a problem for those using other browsers. Yeah, I tested IE, Chrome, Firefox in Win 10, all worked, no problems. Problem exists between chair and keyboard? (PEBCAK) Aka...just trying to make waves...” As in dropping a pebble into a perfectly smooth pool of water, disturbing the image, breaking it up, creating waves of disturbance that spread outwards from the centre.”
|
|
|
Post by traderdennis on Mar 31, 2018 11:20:02 GMT -5
I just checked www.afrezza.com/hcp/ and had no problem, huge or otherwise, in "learning more" about Spirometry. I'm using Chrome as my Windows 10 browser. Maybe the problem has been fixed or it's only a problem for those using other browsers. I tried it using opera and it worked fine as well. Now, though, the doctors gets to see up front, "AFREZZA causes a decline in lung function over time as measured by FEV1," and probably doesn't read any further before going to check their email. It looks like an issue with Internet Explorer, it literally took 30+ seconds to load. It probably is a retargeting pixel that is failing and not allowing the site to fully render until the pixel fails in transmission. I did not see an issue with Chrome. It would not be the first time a website is incompatible, but totally unprofessional for the marketing company not to run a check with an IE browser with its many known incompatibility issues. I am running IE11 with Windows 7 professional. And yes, a technology challenged doctor is likely to be using IE as it is the default browser that comes on a windows machine.
|
|
|
Post by sportsrancho on Mar 31, 2018 11:29:57 GMT -5
|
|
|
Post by nylefty on Mar 31, 2018 12:01:35 GMT -5
I tried it using opera and it worked fine as well. Now, though, the doctors gets to see up front, "AFREZZA causes a decline in lung function over time as measured by FEV1," and probably doesn't read any further before going to check their email. It looks like an issue with Internet Explorer, it literally took 30+ seconds to load. It probably is a retargeting pixel that is failing and not allowing the site to fully render until the pixel fails in transmission. I did not see an issue with Chrome. It would not be the first time a website is incompatible, but totally unprofessional for the marketing company not to run a check with an IE browser with its many known incompatibility issues. I am running IE11 with Windows 7 professional. And yes, a technology challenged doctor is likely to be using IE as it is the default browser in a windows machine. Actually, Microsoft Edge is the default browser for Windows 10 machines. It came with the Dell desktop I bought a couple of years ago. I never use it, but made an exception to check out the supposed "huge" problem and had no problem at all.
|
|
|
Post by traderdennis on Apr 1, 2018 11:30:59 GMT -5
It looks like an issue with Internet Explorer, it literally took 30+ seconds to load. It probably is a retargeting pixel that is failing and not allowing the site to fully render until the pixel fails in transmission. I did not see an issue with Chrome. It would not be the first time a website is incompatible, but totally unprofessional for the marketing company not to run a check with an IE browser with its many known incompatibility issues. I am running IE11 with Windows 7 professional. And yes, a technology challenged doctor is likely to be using IE as it is the default browser in a windows machine. Actually, Microsoft Edge is the default browser for Windows 10 machines. It came with the Dell desktop I bought a couple of years ago. I never use it, but made an exception to check out the supposed "huge" problem and had no problem at all. Per Adobe Site Catalyst, Microsoft is the third most popular browser behind Chrome and Safari at 11%. Of the Microsoft browser platforms, IE 11 is 57%, the Edge flavors make up about 38% with the remaining 5% to older versions of IE, down to still a few using IE 6 and IE 7. Point, is about 4-5% of web traffic is IE11 enought of a load to make sure their developers should be testing pixels with it.
|
|
|
Post by peppy on Apr 1, 2018 11:46:46 GMT -5
So we have determined SO is lying? or has an old computer? an old operating system? Alrighty then. He probably lives in his mother's basement? Just saying. Some mysterious person with a lap top that writes trash for SA?
Happy holidays.
|
|
|
Post by od on Apr 2, 2018 6:53:25 GMT -5
For a variety of reasons I have had 5-6 Dr's (different) office visits in the last several months. In each case at least one, sometimes two different detail men/women=salespeople have come in, tried to see the Dr and was only allowed to fill out the sign in book and not see the Dr as too busy. I wonder how often even an excellent sales person can succeed if denied face to face time with the Dr's? I’ve seen the same thing happen. I’ve also noticed a “sales rep” sitting and waiting and then going in for only a few minutes and then leaving. I think this old sales approach of visiting doctor’s offices has limited effectiveness these days. If that rep was promoting Afrezza, would 3-5 minutes do any good in educating the doctor? I doubt it. In my opinion, the change in the provider/representative interaction dynamic is why MNKD should be exploring RxVantage to secure necessary share-of-voice. There is a reason Amgen, AstraZeneca, GSK, Lilly, Merck, Novo Nordisk, Pfizer, Roche, and Teva are on board to secure time with providers and enhance the communication.
|
|
|
Post by akemp3000 on Apr 2, 2018 7:04:34 GMT -5
Never heard of RxVantage before. Sounds interesting..."New data shows that biopharma firms that provide reps with a subscription to RxVantage realize average of 2.4 times more physician appointments than non-subscribing reps."
|
|
|
Post by mnholdem on Apr 2, 2018 7:36:34 GMT -5
FWIW, I noticed about 6x more reprints of SO's Seeking Alpha article last week - related to increasing sales scripts of Afrezza - than were reprinted for his article about spirometer link "difficulties". Apparently the Wall Street investor rags also don't give as much credibility to SO when he speculates. There definitely are more reprints when he sticks to facts and figures.
I believe that the most common reason that Seeking Alpha moderators often delete replies is because they fall under the criteria highlighted below:
From Seeking Alpha:
Why moderation and oversight?
People say one should never discuss money, politics or religion. Seeking Alpha focuses on the first of these delicate topics.
Passionate discussions are always welcome on the site, but we expect that user posts should be genuine, helpful responses and that users should behave with—and be able to expect—high ethical and intellectual standards from other users. So we will delete posts that we believe detract from civilized conversation and repeat offenders may have their posting privileges revoked. Such material includes, but is not limited to:
- obscenities or abusive language about another user or the topic under discussion
- personal attacks on another user or a contributor
- allegations of bad faith against another user or a contributor
- blanket dismissal of someone else’s ideas
- content that is not directly related to the context (on an article, this includes discussion of the author’s track record or credentials)
- promotion of your own business or website
- unclear or distracting formatting
- thread hijacking
- trolling or provoking another user or a contributor
Source: seekingalpha.com/page/comment_guidelines
---
As a moderator myself, I should point out that my counterparts at Seeking Apha do post a process if you have a complaint, found at the same link (above):
Corrections and disputes
Commenters sometimes alert our team to corrections or disputes about an article in their comments. Our team tries to forward such comments to the appropriate Seeking Alpha department, but we remind you that you can email corrections@seekingalpha.com for minor or typographical errors in analysis articles, and mc-corrections@seekingalpha.com for mistakes in Breaking News items. If you wish to file a formal complaint about an article, you should email disputes@seekingalpha.com, following the dispute [guidelines][sp]. If you believe that an author or another user is receiving undisclosed payment for writing on Seeking Alpha, please send evidence to integrity@seekingalpha.com
If you wish to contact the moderation team, please email us at moderation@seekingalpha.com. Please include your Seeking Alpha username and the URL of relevant comments, articles etc. We cannot respond to all queries we receive, but we will assess them according to the constraints of our workflow.
|
|
|
Post by peppy on Apr 2, 2018 9:01:51 GMT -5
FWIW, I noticed about 6x more reprints of SO's Seeking Alpha article last week - related to increasing sales scripts of Afrezza - than were reprinted for his article about spirometer link "difficulties". Apparently the Wall Street investor rags also don't give as much credibility to SO when he speculates. There definitely are more reprints when he sticks to facts and figures.
I believe that the most common reason that Seeking Alpha moderators often delete replies is because they fall under the criteria highlighted below:
From Seeking Alpha:
Why moderation and oversight?
People say one should never discuss money, politics or religion. Seeking Alpha focuses on the first of these delicate topics.
Passionate discussions are always welcome on the site, but we expect that user posts should be genuine, helpful responses and that users should behave with—and be able to expect—high ethical and intellectual standards from other users. So we will delete posts that we believe detract from civilized conversation and repeat offenders may have their posting privileges revoked. Such material includes, but is not limited to:
- obscenities or abusive language about another user or the topic under discussion
- personal attacks on another user or a contributor
- allegations of bad faith against another user or a contributor
- blanket dismissal of someone else’s ideas
- content that is not directly related to the context (on an article, this includes discussion of the author’s track record or credentials)
- promotion of your own business or website
- unclear or distracting formatting
- thread hijacking
- trolling or provoking another user or a contributor
Source: seekingalpha.com/page/comment_guidelines
---
As a moderator myself, I should point out that my counterparts at Seeking Apha do post a process if you have a complaint, found at the same link (above):
Corrections and disputes
Commenters sometimes alert our team to corrections or disputes about an article in their comments. Our team tries to forward such comments to the appropriate Seeking Alpha department, but we remind you that you can email corrections@seekingalpha.com for minor or typographical errors in analysis articles, and mc-corrections@seekingalpha.com for mistakes in Breaking News items. If you wish to file a formal complaint about an article, you should email disputes@seekingalpha.com, following the dispute [guidelines][sp]. If you believe that an author or another user is receiving undisclosed payment for writing on Seeking Alpha, please send evidence to integrity@seekingalpha.com
If you wish to contact the moderation team, please email us at moderation@seekingalpha.com. Please include your Seeking Alpha username and the URL of relevant comments, articles etc. We cannot respond to all queries we receive, but we will assess them according to the constraints of our workflow.
I posted this as a response to SO articles, I believe it was removed. In other news, media outlets.... fair and balanced? www.nytimes.com/2018/04/02/business/media/sinclair-news-anchors-script.htmlOur media bought and paid for.
|
|